Eszopiclone for the Treatment of PTSD
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2016
At a glance
- Drugs Eszopiclone (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 14 Apr 2016 Status changed from recruiting to completed.
- 20 Oct 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
- 20 Oct 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.